Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000547072 | SCV000644878 | pathogenic | Familial hemophagocytic lymphohistiocytosis 2 | 2024-02-19 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 450 of the PRF1 protein (p.Thr450Met). This variant is present in population databases (rs189650890, gnomAD 0.01%). This missense change has been observed in individual(s) with familial hemophagocytic lymphohistiocytosis (PMID: 15632205, 15728124, 17266056, 18074390, 20092789, 21152410, 21881043, 25233452, 25297583, 26903364). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 468301). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PRF1 protein function. Experimental studies have shown that this missense change affects PRF1 function (PMID: 15632205, 19487666). For these reasons, this variant has been classified as Pathogenic. |
Hudson |
RCV000547072 | SCV000993625 | pathogenic | Familial hemophagocytic lymphohistiocytosis 2 | 2019-03-26 | criteria provided, single submitter | research | |
Revvity Omics, |
RCV001783053 | SCV002024742 | likely pathogenic | not provided | 2019-01-03 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003476292 | SCV004204180 | pathogenic | Aplastic anemia | 2024-02-21 | criteria provided, single submitter | clinical testing | |
Genomic Medicine Center of Excellence, |
RCV000547072 | SCV004808173 | pathogenic | Familial hemophagocytic lymphohistiocytosis 2 | 2024-03-29 | criteria provided, single submitter | clinical testing | |
Genetics and Genomic Medicine Centre, |
RCV000547072 | SCV005873656 | likely pathogenic | Familial hemophagocytic lymphohistiocytosis 2 | 2020-08-23 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV005398810 | SCV006057923 | pathogenic | Aplastic anemia; Familial hemophagocytic lymphohistiocytosis 2; Lymphoma, non-Hodgkin, familial | 2023-01-16 | criteria provided, single submitter | research |